NicOx presents promising preclinical results in the fields of ophthalmology and pain
NicOx SA announced that two drug candidates, representing new classes of nitric oxide (NO)-donating compounds based on the company’s NO-donating R&D platform, have moved into preclinical research with preclinical data presented at scientific conferences for the first time.
All About Blepharoplasty Surgery : Bruising Effects in Blepharoplasty